#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

Idiopathic Pulmonary Fibrosis from the Perspective of an Outpatient Pulmonologist

16. 4. 2020 Source: Pulmonary Fibrosis

Idiopathic pulmonary fibrosis represents a rare disease of lung tissue with an as-yet-unexplained etiology. In the framework of differential diagnosis, it is necessary to consider the disease, as early diagnosis combined with the deployment of antifibrotic therapy extends patients' lives.

z UL

Thinking About Idiopathic Pulmonary Fibrosis?

Idiopathic pulmonary fibrosis (IPF) is one of the most prognostically severe and difficult-to-treat…
16. 4. 2020 Source: Pulmonary Fibrosis
Muž se chytá za srdce

American Heart Association: Side Effects of Statins Overview and Context

The American Heart Association (AHA) report provides an updated summary of knowledge on the safety…
15. 4. 2020 Source: Cardiovascular Risks
histologie_genetika_onkologie

Third Generation Targeted Therapy for ROS1-Positive NSCLC

The potent third-generation tyrosine kinase inhibitor, lorlatinib, has shown activity in…
15. 4. 2020 Source: Genetic Profile and Treatment of NSCLC
rentgen_plic_snimek

Key Role of HRCT in Diagnosing Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis is often an unjustly overlooked disease. The truth is that it is a…
15. 4. 2020 Source: Pulmonary Fibrosis
Výběr inkontinenční pomůcky dle absorpce

The Choice of Incontinence Aids Matters − But How Not to Get Lost Among Them?

Despite significant advances in medicine, a large number of patients still struggle with…
14. 4. 2020 Source: Incontinence
PL_glukometr_diabetes

Prevalence of Diabetics Among Patients with COVID-19 and the Impact of DM on the Course of Infection

Italian authors published the results of a meta-analysis of studies at the end of March, assessing…
14. 4. 2020 Source: Modern Treatment of Diabetes
Idiopatická plicní fibróza

Idiopathic Pulmonary Fibrosis: Rare Disease with Severe Prognosis

Idiopathic pulmonary fibrosis (IPF) represents a diagnostic and therapeutic challenge. This rare…
14. 4. 2020 Source: Pulmonary Fibrosis

Impact of Empagliflozin on the Risk of Cardiovascular Death and Need for Hospitalization Due to Heart Failure

In the EMPA-REG OUTCOME study, empagliflozin reduced the risk of cardiovascular death and the number...
10. 4. 2020 Source: Diabetes
PL_duchodkyne_seniorka_pece

Domestic application of biological asthma treatment improves quality of life and reduces doctor visits

The benefits of the possibility of home application of omalizumab, a monoclonal antibody indicated…
9. 4. 2020 Source: Asthma under control
1 146 147 148 149 150 160
Filter by speciality
Remove filters

Conferences

News from the world of medicine

16. 1.
Léčba rány
XIII. Celostátní kongres České společnosti pro léčbu rány s mezinárodní účastí

All conferences
Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#